Item 1.01 Entry into a Material Definitive Agreement.
On July 8, 2009, MetLife, Inc., a Delaware corporation ("MetLife"),
completed a public offering of $500,000,000 aggregate principal amount of its
10.750% Fixed-to-Floating Rate Junior Subordinated Debentures due 2069 (the
"junior subordinated debentures"). The terms of the junior subordinated
debentures are set forth in an Indenture, dated as of June 21, 2005 (attached as
Exhibit 4.5 to MetLife's Current Report on Form 8-K dated June 22, 2005 and
incorporated herein by reference), between MetLife and The Bank of New York
Mellon Trust Company, N.A. (as successor to J.P. Morgan Trust Company, National
Association), as trustee (the "Trustee"), as supplemented by the Eighth
Supplemental Indenture, dated as of July 8, 2009 (attached hereto as Exhibit 4.1
and incorporated herein by reference), among MetLife, the Trustee and J.P.
Morgan Securities Inc., as premium calculation agent.
The junior subordinated debentures were issued pursuant to an underwriting
agreement (the "Underwriting Agreement") and a pricing agreement (the "Pricing
Agreement"), each dated as of June 30, 2009, among MetLife and J.P. Morgan
Securities Inc. and Morgan Stanley & Co. Incorporated, as representatives of the
several underwriters named in Schedule I to the Pricing Agreement (the
"Underwriters"). Pursuant to the Underwriting Agreement and Pricing Agreement
(attached as Exhibits 1.1 and 1.2, respectively, to MetLife's Current Report on
Form 8-K dated July 2, 2009 and incorporated herein by reference), and subject
to the terms and conditions expressed therein, MetLife agreed to sell the junior
subordinated debentures to the Underwriters, and the Underwriters agreed to
purchase the junior subordinated debentures for resale to the public.
On July 8, 2009, in connection with the completion of the offering of the
junior subordinated debentures, MetLife entered into a replacement capital
covenant (the "Replacement Capital Covenant") (attached hereto as Exhibit 4.2
and incorporated herein by reference), whereby MetLife agreed for the benefit of
holders of a series of MetLife's long-term indebtedness designated by MetLife in
accordance with the terms of the Replacement Capital Covenant from time to time
ranking senior to the junior subordinated debentures that the junior
subordinated debentures will not be repaid, redeemed or purchased by MetLife, on
or before August 1, 2059, unless such repayment, redemption or purchase is made
from the proceeds of the issuance of certain replacement capital securities and
pursuant to the other terms and conditions set forth in the Replacement Capital
Covenant.
The junior subordinated debentures were offered and sold by MetLife pursuant
to its registration statement on Form S-3 (File No. 333-147180) and a prospectus
supplement dated June 30, 2009.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an
Off-Balance Sheet Arrangement of a Registrant.
The information set forth, and the exhibits identified, in Item 1.01 are
incorporated herein by reference.
Item 3.03 Material Modification to Rights of Security Holders.
The information set forth, and the exhibits identified, in Item 1.01 are
incorporated herein by reference.
Item 8.01 Other Events.
The information set forth, and the exhibits identified, in Item 1.01 are
incorporated herein by reference.
On July 8, 2009, Dewey & LeBoeuf LLP, special counsel to MetLife, issued an
opinion and consent (attached hereto as Exhibits 5.1 and 23.1, respectively, and
incorporated herein by reference) as to the validity of the junior subordinated
debentures. Also on July 8, 2009, Debevoise & Plimpton LLP, special tax counsel
to MetLife, issued an opinion and consent (attached hereto as Exhibits 8.1 and
23.2, respectively, and incorporated herein by reference) regarding certain U.S.
Federal income tax matters.
Item 9.01 Financial Statements and Exhibits.
(a) Not applicable
(b) Not applicable
(c) Not applicable
(d) Exhibits
4.1 Eighth Supplemental Indenture dated as of July 8, 2009 to the Subordinated
Indenture between MetLife, Inc. and The Bank of New York Mellon Trust
Company, N.A. (as successor to J.P. Morgan Trust Company, National
Association), as trustee, and J.P. Morgan Securities Inc., as premium
calculation agent.
4.2 Replacement Capital Covenant dated as of July 8, 2009.
4.3 Form of junior subordinated debenture (included in Exhibit 4.1 above).
5.1 Opinion of Dewey & LeBoeuf LLP.
8.1 Opinion of Debevoise & Plimpton LLP.
23.1 Consent of Dewey & LeBoeuf LLP (included in Exhibit 5.1 above).
23.2 Consent of Debevoise & Plimpton LLP (included in Exhibit 8.1 above).